> ## Content Index > Fetch the complete content index at: https://www.thekadefrequency.com/llms.txt > Use this file to discover other available public pages before exploring further. # The Wrong Strain: Why This Ebola Has No Vaccine - URL: https://www.thekadefrequency.com/the-wrong-strain-ebola-bundibugyo-no-vaccine/ - Published: 2026-08-09T08:00:33.000Z - Updated: 2026-08-09T08:00:33.000Z - Description: There is a vaccine for Ebola. It doesn't work on the one killing Congo, a species nobody cured in nineteen years. Then it reached a German hospital. - Author: A. Kade - Tags: captured class, Africa, health, #featured, #deep-dive, #the-wrong-strain **Ebola is now killing people in eastern Congo faster than it has ever killed anyone, anywhere. There is a vaccine for Ebola. There are two licensed treatments. None of them work on this one, because this is a different species, and that species has spent nineteen years killing Africans without anybody building a cure. This year it reached a hospital in Germany, and another in France, and suddenly the research is moving at what the World Health Organization itself calls unprecedented speed.** By A. Kade --- In Bunia, in Ituri province, a man called Anicet Baluku buried two brothers and then told the Associated Press why he thought they had died. Not the virus. The strike. The people who treat Ebola patients in eastern Congo, the ones in the suits, who carry the bodies, who hold the line between an outbreak and an epidemic, stopped working, because they had not been paid. Not since May, when this began. Some of them began receiving money only in the last days of July, for three months of work, and they are still asking for wages that would make the job survivable. In the meantime, at the epicentre of the fastest-growing Ebola epidemic on record, the response paused. *We urge the authorities to quickly find a solution,* Baluku said, *to prevent other families from experiencing the same tragedy.* He is being extraordinarily polite. I do not intend to be. ••• Start with the scale, because it is worse than the coverage suggests and the coverage has been thin. The outbreak was declared on **15 May 2026** in Ituri, in the far east of the **Democratic Republic of the Congo**. The first infection is now thought to have occurred in January, in the gold-mining town of Mongbwalu, with the death of a woman nobody was looking for. Patient zero has never been identified. [**The World Health Organization**](https://www.who.int/health-topics/ebola?ref=thekadefrequency.com#tab=tab%5F1)'s last full update, covering data to 30 July, recorded 3,605 confirmed cases in the DRC and 1,587 deaths, a crude fatality ratio of 44 per cent. In the most recent complete reporting week it counted the highest weekly figures of the entire outbreak: 567 new cases, 296 deaths. By the first week of August, Congolese government figures had passed 1,800 dead, and later that week the authorities put the number at around 1,850. It has spread across five provinces and forty-nine health zones, with transmission still active in thirty-three of them. Ituri accounts for 88 per cent of confirmed cases and 83 per cent of the deaths. More than seventeen thousand contacts are being monitored. This is now the largest Ebola outbreak ever recorded in the Democratic Republic of the Congo, surpassing the 2018-2020 epidemic, and the second largest anywhere in history. And then there is the number underneath the number. The confirmed count is a floor, not a measure. Between 55 and 60 per cent of cases cannot be linked to a known source, which means the chains of transmission are largely invisible. The World Health Organization's own internal working estimate, unpublished, puts the true number of infections at three to four times the confirmed figure, somewhere between eleven and fifteen thousand. A nowcast maintained at the London School of Hygiene and Tropical Medicine brackets it lower, between roughly 5,700 and 11,200, with ninety per cent confidence. Take the most conservative of those and the outbreak is still twice as large as anyone is counting. The reproduction number sits at 1.1, which means it is still growing. ••• Now the thing this piece is actually about. There is a vaccine for [**Ebola**](https://en.wikipedia.org/wiki/Ebola?ref=thekadefrequency.com). It works. It is called [**Ervebo**](https://www.ema.europa.eu/en/medicines/human/EPAR/ervebo?ref=thekadefrequency.com), it was licensed in 2019, and its deployment record genuinely deserves the word remarkable, ring vaccination around confirmed cases, transmission chains severed, outbreaks that would once have run for a year closed down in weeks. There are also two licensed monoclonal antibody treatments, Inmazeb and Ebanga, which substantially reduce the chance that an infected person dies. Between them they have saved a great many Congolese lives. None of them are being used to stop this. They cannot be. Ervebo, Inmazeb and Ebanga were all developed, trialled and licensed against [***Zaire ebolavirus***](https://en.wikipedia.org/wiki/Zaire%5Febolavirus?ref=thekadefrequency.com). The virus burning through Ituri is *Bundibugyo ebolavirus*, a different species of the same genus. The vaccine provides no established protection against it. The treatments do not work on it. For Bundibugyo, until this summer, there was no approved vaccine, no approved treatment, and, until 2 July of this year, not even a diagnostic test with WHO emergency listing. There was supportive care: fluids, oxygen, the management of symptoms. And there was luck. **Forty-four per cent.** ••• So: why does one species of Ebola have a vaccine and the other does not? Not because Zaire is more dangerous. Both kill on a scale that beggars description. Not because Bundibugyo is new. It was identified in 2007, in the Ugandan district it is named after. It caused a second outbreak in Congo in 2012\. It has been a known, sequenced, characterised human pathogen for nineteen years. Not because a vaccine is impossible. The platform that produced Ervebo, an Ebola surface protein carried on a harmless virus, is not species-specific in principle. Candidates for Bundibugyo exist. Two of them are in trials right now. The answer is 2014. In that year, Zaire ebolavirus got out of West Africa. It killed more than eleven thousand people, and, this is the part that mattered, it put infected patients on aeroplanes to Madrid, to London, to Dallas, to Hamburg. It produced photographs of American nurses in isolation wards and a headline in every wealthy country on earth. Within about two years, the money, the regulatory urgency, the trial infrastructure and the political will that had all been unavailable for the previous four decades materialised at once, and a vaccine that had been sitting in various stages of development since the 1990s was completed, tested and licensed. Bundibugyo never did that. It stayed where it started, in eastern Congo, in western Uganda, in districts with no direct flights to anywhere that writes health policy. It killed people quietly, in outbreaks small enough to be contained by exhausted local staff and large enough to be forgotten within a month. So nobody built the vaccine. Not because anyone decided Ituri should be left to it, because a vaccine against a pathogen that appears sporadically among people with no money is a product without a purchaser, and there is no mechanism in the world that reliably makes such things exist. **The mechanism is not evil. That would be easier.** [**The mechanism**](https://www.thekadefrequency.com/the-order-book-arms-industry-extraction-machine/) **is a spreadsheet.** ••• And now the part that arrived while I was writing this, and which sharpens the argument rather than blunting it. Things are finally moving. I want to say that plainly and give it its full weight, because it is true and it matters. On 2 July, WHO added the first diagnostic test for Bundibugyo virus to its Emergency Use Listing. On the same day, patient enrolment began in a trial to identify the first effective treatments for the disease. In June, WHO and the Africa CDC launched a joint continental response plan and WHO issued comprehensive filovirus guidelines. Two post-exposure prophylaxis trials are now running inside Ituri itself. And earlier this month the World Health Organization stated that trials of experimental treatments, preventive medicines and vaccines for Bundibugyo are advancing *at unprecedented speed*. Good. All of it. These are serious people doing difficult work under impossible conditions and none of this is easy. Now look at when it started. Nineteen years after the species was identified. Fourteen years after its second outbreak. Three months into an epidemic that has become the largest in Congolese history. And in the same summer that Bundibugyo ebolavirus, for the first time, reached Europe. *A humanitarian worker, a US citizen, medically evacuated from the DRC to Germany in May. A second, also evacuated to Germany, on 13 July. And a confirmed case reported in France on 24 June.* I cannot prove those three patients caused the acceleration, and I am not going to claim it. The outbreak's scale alone would justify everything WHO has done. But I can observe the sequence, and I would ask you to observe it too: nineteen years of nothing, and then, in the year the disease kills eighteen hundred people *and* turns up in a German isolation ward, everything that had been impossible becomes possible at unprecedented speed. **The machinery is not broken. That was never the finding. The machinery works beautifully.** **It just needs the right patients.** ••• One further detail, which I have not been able to put down. There are two vaccine trials for Bundibugyo running at this moment. They are in the United Kingdom and Canada. There are legitimate reasons for early-phase safety trials to run in stable, well-equipped settings, and I will come to them. Hold the picture anyway. Eighty-eight per cent of the world's cases are in one Congolese province. The trials for the vaccine against the thing killing them are being conducted in two of the safest countries on earth, where the disease does not exist, has never existed, and never will. ••• Here is the strongest case against everything I have written. It comes in three parts, and all three are serious. **Vaccine development against sporadic pathogens is structurally, genuinely hard.** To license a vaccine you must show it works, and to show it works you need an outbreak, enough cases, in one place, at the same time as your trial, with an ethical design. For a virus that surfaces once every few years in a different remote district, this is close to impossible. Ervebo was only completed because West Africa in 2014 supplied, horribly, the conditions under which a trial could run. The scientists working on Bundibugyo have been trying to develop a vaccine against a disease that would not hold still long enough to be tested. **Early-phase trials belong where they can be run safely.** Phase 1 studies test safety and immune response in small numbers of healthy volunteers. Running those in Britain and Canada is not a moral failure; it is how the pipeline works, and it protects the people who would otherwise be first to receive an untested product. **And the Congolese state is not a bystander.** The health workers of Ituri were not left unpaid by the World Health Organization or by a pharmaceutical company. They were left unpaid by their own government, in a province where the state's authority is contested by armed groups and where the health system was broken long before this virus arrived. Any account that places the entire weight on distant institutions is a flattering fiction that lets Kinshasa off. I accept all of it. Every word. Now here is what it does not explain. It does not explain why, in the eleven years since the world learned that Ebola could reach a hospital in Dallas, the international system produced a licensed vaccine for exactly one species, the one that had frightened it, and then stopped. It does not explain why the pandemic-preparedness architecture built after 2014, created precisely so that this would not happen again, did not deliver a licensed countermeasure for the other Ebola species in a decade. It does not explain why a pathogen with two prior outbreaks and a nineteen-year-old genome sat in the queue until the summer the bodies reached four figures. And it does not explain why every one of those difficulties, which are cited now as the reason nothing was ready, proved surmountable inside twenty-four months for Zaire ebolavirus in 2014. The difficulty is real. The difficulty is also the alibi. It was never impossible. It was never even especially expensive. It was simply never urgent, and urgency in this system is not generated by how many people are dying. It is generated by who they are, and by whether the thing killing them can reach a departure lounge. ••• There is a woman in Bunia named Esther Lutula. She is twenty-six, four months pregnant, and already the mother of four children. When the outbreak started she stopped going for prenatal checkups. Think about what that decision actually is. She has calculated, correctly, on the information available to her, that a health facility in Ituri right now is more likely to kill her than to help her. So she has removed herself and her unborn child from medical care in a province where maternal mortality was already among the worst in the world. That is the second epidemic, the one that never appears in a case count. The clinics that empty. The vaccinations that stop. The births that happen at home. The malaria left untreated because the nearest facility has become a place where people go to die of something else. In West Africa in 2014, the collateral deaths, measles, malaria, HIV, childbirth, are estimated to have rivalled the deaths from Ebola itself. Nobody will ever count Ituri's. There is no mechanism for counting them and no constituency demanding the number. Meanwhile the Director-General of the World Health Organization flew into Kinshasa this week. The head of the Africa CDC made his second visit to Bunia. Both of these things are good and both of these men are doing their jobs. And the people who carry the bodies had not been paid since May. ••• I keep returning to the arithmetic, because the arithmetic is the argument and it needs no adjectives from me. **Two species of the same virus. One of them killed Africans for decades and then, on a handful of occasions, briefly threatened Europeans and Americans, and it has a vaccine and two treatments, developed at speed, deployed with real success, saving Congolese lives in outbreak after outbreak.** The other has only ever killed Africans. It has been known for nineteen years. Until this summer it had no vaccine, no treatment, and no emergency-listed diagnostic test. The vaccine trials that might one day change that are running on two other continents. And the acceleration everybody is now rightly proud of began in the same season the disease first appeared in a German hospital. Forty-four per cent. Perhaps eighteen hundred and fifty dead, and perhaps three times that many infected than anyone has counted, and the curve still rising, and more than half of all new cases arriving from chains nobody can trace. There is no villain in this piece. I have looked for one and there is not a single person I can name who chose this outcome. There is only a system that allocates the capacity to prevent death according to the purchasing power and the fear of the people who might die, and which has now been asked, seventeen times in one country, whether it would like to reconsider. The virus is not the wrong strain. The virus is doing exactly what it has always done. We are the wrong strain. We solve what frightens us and we let the rest run, and then we move at unprecedented speed once the numbers get large enough to be embarrassing or the patients get close enough to be us, and we call the result a tragedy, as though a tragedy were something that happens to people, rather than something decided about them, years in advance, in rooms where none of them have ever set foot. ••• [***A. Kade***](https://www.thekadefrequency.com/about/) *writes* [***The Kade Frequency***](https://www.thekadefrequency.com/)*, an investigative publication on institutional power, financial capture, and the long project of making democracy something real.* *No sponsors. No filters. No propaganda.* ••• **Sources and references** **The outbreak.** The outbreak was declared in Ituri province on 15 May 2026 and designated a Public Health Emergency of International Concern by the World Health Organization on 16-17 May. The World Health Organization's Disease Outbreak News covering data to 30 July 2026 reported 3,605 confirmed cases and 1,587 deaths in the Democratic Republic of the Congo, a crude case fatality ratio of 44 per cent, spread across five provinces (Ituri, North Kivu, South Kivu, Haut-Uélé and Tshopo) and 49 health zones with active transmission in 33, and recorded the highest weekly totals of the outbreak in epidemiological week 30 (567 cases and 296 deaths). The same source confirms this is now the largest Ebola outbreak ever recorded in the DRC, surpassing the 2018-2020 outbreak of 3,317 confirmed cases. UN News reported that Ituri accounts for 88 per cent of confirmed cases and 82.6 per cent of deaths. Government figures reported by Al Jazeera on 4 August 2026 put the toll at 1,707 deaths from 3,802 cases, with more than 17,000 contacts being monitored and roughly 80 per cent followed up daily. Figures compiled in the first week of August recorded 1,801 confirmed deaths in the DRC, with Congolese authorities subsequently citing approximately 1,850\. The European Centre for Disease Prevention and Control's next epidemiological update was scheduled for 10 August 2026. **Undercounting.** The finding that 55 to 60 per cent of cases lack an identifiable source, that WHO's unpublished internal working estimate places true infections at three to four times the confirmed count (approximately 11,500 to 15,300), that a London School of Hygiene and Tropical Medicine nowcast brackets total infections between roughly 5,700 and 11,200 with 90 per cent probability, and that the reproduction number remains at approximately 1.1, are drawn from analysis by John M. Drake published in Forbes on 4 August 2026, citing WHO correspondence, WHO Disease Outbreak News and the LSHTM nowcast. **The strain.** The outbreak is caused by *Bundibugyo ebolavirus*, first identified in Uganda in 2007-2008 and responsible for a subsequent outbreak in Isiro, DRC, in 2012\. The licensed Ebola vaccine Ervebo (rVSV-ZEBOV) and the licensed monoclonal antibody treatments Inmazeb and Ebanga are approved against *Zaire ebolavirus*. Contemporaneous coverage of this outbreak, including WHO materials, has noted that existing Ebola countermeasures were certified for a different species, complicating the response. **Research acceleration.** WHO added the first diagnostic test for Bundibugyo virus to its Emergency Use Listing on 2 July 2026, and patient enrolment in a trial to identify the first effective treatments for Bundibugyo virus disease began the same day, both announced on WHO's outbreak page. Africa CDC and WHO launched a joint continental response plan on 5 June 2026, and WHO issued comprehensive filovirus guidelines on 17 June 2026\. Al Jazeera reported on 4 August 2026 that WHO described trials of experimental treatments, preventive medicines and vaccines as advancing at unprecedented speed. Two post-exposure prophylaxis trials are running in Ituri province and two vaccine trials in the United Kingdom and Canada, as reported by the Associated Press. **Cases outside Africa.** A US citizen was medically evacuated from the DRC to Germany in May 2026; a second laboratory-confirmed case in an American humanitarian worker evacuated to Germany was notified to WHO on 13 July 2026; and a further imported case was reported in France on 24 June 2026, per the European Centre for Disease Prevention and Control. Uganda reported 20 confirmed cases and two deaths, with its last case reported on 21 June, and declared its outbreak over on 28 July 2026. **The strike.** The strike by front-line health workers in Ituri over unpaid and inadequate wages, the fact that some workers began receiving payment only in the final week of July for work performed since May, and the account of Anicet Baluku of Bunia attributing his two brothers' deaths to the strike, were reported by the Associated Press. The account of Esther Lutula, a 26-year-old pregnant mother of four who stopped attending prenatal checkups, is from the same reporting. **Context on the 2014-2016 West African epidemic**, including more than 11,000 deaths, exported cases to Europe and the United States, and the resulting acceleration of Ebola vaccine development, is from the standard epidemiological record. The piece's central analytical claim, that the presence of a licensed vaccine for one Ebola species and its long absence for another reflects the allocation of biomedical urgency according to the fear and purchasing power of wealthy countries rather than the burden of disease, is the piece's own. The piece does not assert that the imported European cases caused the 2026 acceleration in Bundibugyo research, only that the sequence is a matter of record. The facts on which it rests are in the public record. By the same author ### Two books in restrained literary nonfiction A. Kade's companion volumes, a meditation on thinking and character, and a meditation on love, real and imagined. [View the books →](https://www.thekadefrequency.com/books/)